Academician
ABDULLAH YALÇIN
PROFESÖR
BURSA ULUDAĞ ÜNİVERSİTESİ VETERİNER FAKÜLTESİ VETERİNER HEKİMLİĞİ TEMEL BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Veteriner Biyokimyası
A quick look at recorded outputs — details below.
- Articles 32
- Projects 0
- Books 0
- Proceedings 34
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
13
Q2
3
Q3
4
Q4
0
WoS (JCR)
Q1
5
Q2
9
Q3
5
Q4
1
TR Index
2
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
5
Avg percentile
66.7%
Top 1% share
0.0%
Top 10% share
27.8%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2023 Increased expression of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for growth of mouse embryonic stem cells that are undergoing differentiation YÖKSİS SJR Q3 JCR Q3 OpenAlex 39.4%
- 2023 Transforming growth factor β1 upregulates 6‐phosphofructo‐2‐kinase/fructose 2,6‐bisphosphatase‐4 expression in A549 and MCF‐10A cells YÖKSİS SJR Q2 JCR Q3 OpenAlex 10.1%
- 2023 Expression of Pfkfb isoenzymes during in vitro differentiation of mouse embryonic stem cells into insulin-producing cells YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 67.7%
- 2023 Expression of dual-specificity phosphatases in TGFß1-induced EMT in SKOV3 cells YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 57.6%
- 2022 Upregulation of dual-specificity phosphatase-26 is required for transforming growth factor β1(TGFβ1)-induced Epithelial-mesenchymal transition in A549 and PANC1 cells YÖKSİS SJR Q2 JCR Q3 OpenAlex 47.9%
- 2022 Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor β1-induced migration and drug resistance in A549 cells in vitro YÖKSİS SJR Q1 JCR Q2 OpenAlex 62.6%
- 2021 Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS transformed pancreatic cells YÖKSİS SJR Q1 JCR Q3 OpenAlex 62.2%
- 2017 PFKFB2: Different roles of distinct splices YÖKSİS SJR Q1 JCR Q1 OpenAlex 11.8%
- 2017 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.5%
- 2014 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 94.3%
- 2012 Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.4%
- 2011 A novel small molecule antagonist of choline kinase that simultaneously suppresses MAPK and PI3K AKT signaling YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.3%
- 2009 Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K AKT signaling YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.9%
- 2009 Nuclear targeting of 6 phosphofructo 2 kinase PFKFB3 increases proliferation via cyclin dependent kinases YÖKSİS OpenAlex top 10% OpenAlex 94.4%
- 2009 Regulation of glucose metabolism by 6 phosphofructo 2 kinase fructose 2 6 bisphosphatases in cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 96.9%
- 2008 Small molecule inhibition of 6 phosphofructo 2 kinase activity suppresses glycolytic flux and tumor growth YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 95.6%
- 2023 Pfkfb3 Regulates Epithelial-To-Mesenchymal Transition in Tumor Cells YÖKSİS
- 2022 Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor β1-induced migration and drug resistance in A549 cells in vitro YÖKSİS SJR Q1 JCR Q2 OpenAlex 62.6%
- 2020 PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells YÖKSİS SJR Q2 JCR Q3
- 2015 Tümür hücrelerinde slug ekspresyonunun PFKFB2 tarafından regülasyonu YÖKSİS SJR Q3 JCR Q4